Niagen Bioscience (NAGE) vs USANA Health Sciences (USNA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
USANA Health Sciences (USNA) has outperformed Niagen Bioscience (NAGE) over the past year, losing 44.7% versus a loss of 64.2%. Over five years, NAGE leads with a -58.2% price change compared with -85.2% for USNA. USANA Health Sciences is the larger company by market cap ($270.9 million vs $210.5 million), about 1.3 times the size.
On valuation, USANA Health Sciences trades at a lower forward P/E (8.3x vs 26.6x for Niagen Bioscience).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NAGE | USNA |
|---|---|---|
| Share price | $2.66 | $14.66 |
| Market cap | $210.48M | $270.87M |
| 1-day change | -2.21% | -0.07% |
| YTD return | -58.18% | -25.32% |
| 1-year return | -64.20% | -44.70% |
| 5-year return | -58.18% | -85.20% |
| P/E ratio (TTM) | 14.00 | — |
| Forward P/E | 26.60 | 8.28 |
| EPS (TTM) | $0.19 | $-1.20 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.95 | $24.33 |
| 52-week low | $2.61 | $12.57 |
| Distance from 52-week high | -66.54% | -39.75% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +354.14% | +70.53% |
| Average volume | 585.61K | 186.75K |
| Shares outstanding | 79.13M | 18.48M |
| Employees | 117 | 1,570 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- USNA has outperformed NAGE by 19.5 percentage points over the past year.
About Niagen Bioscience
NAGE stock →Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products.
Health Care · Medicinal Chemicals and Botanical Products · 117 employees
About USANA Health Sciences
USNA stock →USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe.
Health Care · Medicinal Chemicals and Botanical Products · 1,570 employees
NAGE vs USNA FAQ
Which is bigger, Niagen Bioscience or USANA Health Sciences?
USANA Health Sciences (USNA) is larger, with a market capitalization of $270.87M compared with $210.48M for Niagen Bioscience (NAGE).
Which stock has performed better over the past year, NAGE or USNA?
USNA returned -44.70% over the past 12 months, compared with -64.20% for NAGE (price return, excluding dividends). Past performance does not predict future results.
Are Niagen Bioscience and USANA Health Sciences in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.